Evidence map›Paper›PMID 39527151›Full record

ArticleInsights into imaging2024

Roles of MRI evaluation of pelvic recurrence in patients with rectal cancer.

Patricia Perola Dantas, Verônica Botelho Teixeira, Carlos Frederico Sparapan Marques, Gerda Feitosa Nogueira, Cinthia D Ortega

Abstract read
In one paragraph

Article in Insights into imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Radiotherapy volume delineation based on MRI andAbdominal radiology (New York) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Patricia Perola DantasInstituto do Cancer do Estado de São Paulo do Hospital das Clinicas ICESP/HCFMUSP, Department of Radiology, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brasil. patricia.perolad@gmail.com.ORCID http://orcid.org/0009-0001-8083-6582
Verônica Botelho TeixeiraInstituto do Cancer do Estado de São Paulo do Hospital das Clinicas ICESP/HCFMUSP, Department of Radiology, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brasil.
Carlos Frederico Sparapan MarquesColorectal Division, Instituto do Cancer do Estado de São Paulo do Hospital das Clinicas ICESP/HCFMUSP, Department of Gastroenterology and Nutrology, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brasil.
Gerda Feitosa NogueiraInstituto do Cancer do Estado de São Paulo do Hospital das Clinicas ICESP/HCFMUSP, Department of Radiology, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brasil.
Cinthia D OrtegaInstituto de Radiologia, Hospital das Clinicas HCFMUSP, Department of Radiology, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, SP, Brasil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developments in the multidisciplinary treatment of rectal cancer with advances in preoperative magnetic resonance imaging (MRI), surgical techniques, neoadjuvant chemoradiotherapy, and adjuvant chemotherapy have had a significant impact on patient outcomes, increasing the rates of curative surgeries and reducing pelvic recurrence. Patients with pelvic recurrence have worse prognoses, with an impact on morbidity and mortality. Although local recurrence is more frequent within 2 years of surgical resection of the primary tumor, late recurrence may occur. Clinical manifestations can vary from asymptomatic, nonspecific symptoms, to pelvic pain, bleeding, and fistulas. Synchronous metastatic disease occurs in approximately 50% of patients diagnosed with local recurrence. MRI plays a crucial role in posttreatment follow-up, whether by identifying viable neoplastic tissues or acting as a tool for therapeutic planning and assessing the resectability of these lesions. Locally recurrent tissues usually have a higher signal intensity than muscle on T2-weighted imaging. Thus, attention is required for focal heterogeneous lesions, marked contrast enhancement, early invasive behavior, and asymmetric appearance, which are suspicious for local recurrence. However, postsurgical inflammatory changes related to radiotherapy and fibrosis make it difficult to detect initial lesions. This study therefore aimed to review the main imaging patterns of pelvic recurrence and their implications for the surgical decision-making process. CRITICAL RELEVANCE STATEMENT: MRI plays a crucial role in the posttreatment follow-up of rectal cancer, whether by identifying viable neoplastic tissues or by acting as a tool for therapeutic planning. This study reviewed the main imaging patterns of pelvic recurrence. KEY POINTS: MRI aids in surgical planning and the detection of pelvic recurrence and postoperative complications. Being familiar with surgical techniques enables radiologists to identify expected MRI findings. Patterns of rectal cancer recurrence have been categorized by pelvic compartments. Neoplastic tissue may mimic postsurgical and postradiotherapy changes. Resectability of pelvic recurrence is highly related to lesion location.

Indexed as

Magnetic resonance imagingPelvic recurrenceRectal cancer

Identifiers

PMID39527151
PMCPMC11554996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.